Ranjith Chandrasena, MD

  • 2Articles
  • 11.8KReads
  • 2015–2022Active
  • 8Collaborators
  • 32Citations

About

Ranjith Chandrasena, MD is affiliated with Chatham-Kent Clinical Trials Research Centre, Chatham, Ontario, Canada. Ranjith Chandrasena has authored or co-authored 2 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2015 and 2022. Their work focuses on Depression (MDD) and Sexual Dysfunction.

Publications

JCP
Quetiapine XR in Comorbid Depression and Anxiety
Original Research

Quetiapine XR in Comorbid Depression and Anxiety

March 21, 2022

Quetiapine is often used off-label for anxiety and as an augmentation agent in treatment-resistant depression. This study evaluated the efficacy and tolerability of quetiapine in augmenting first-line antidepressants for...
, , , et al
PCC
Letter to the Editor

Nabilone and Dementia-Associated Sexual Inhibition

February 19, 2015

A variety of pharmacologic interventions have been utilized to manage behavioral and psychological symptoms of dementia. Is nabilone an effective treatment option for agitation and sexual disinhibition, which are...
, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe